ACUMEN PHARMACEUTICALS INC (ABOS)
US00509G2093 - Common Stock
ChartMill assigns a Buy % Consensus number of 87% to ABOS. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 13.06. This target is 283.99% above the current price.
ABOS was analyzed by 12 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about ABOS.
In the previous month the buy percentage consensus was at a similar level.
ABOS was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-03-27 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-12-12 | Deutsche Bank | Initiate | Buy |
| 2023-08-09 | Credit Suisse | Reiterate | Outperform -> Outperform |
| 2023-08-09 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-07-20 | B of A Securities | Reiterate | Buy |
| 2023-07-17 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-07-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-18 | Cantor Fitzgerald | Initiate | Overweight |
| 2023-03-28 | Credit Suisse | Maintains | Outperform |
| 2023-03-28 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-02-02 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-11-15 | Credit Suisse | Maintains | Outperform |
| 2022-10-05 | BTIG | Maintains | Buy |
| 2022-07-15 | BTIG | Initiate | Buy |
| 2022-06-30 | HC Wainwright & Co. | Initiate | Buy |
| 2022-01-21 | B of A Securities | Upgrade | Neutral -> Buy |
| 2021-07-26 | UBS | Initiate | Buy |
| 2021-07-26 | Stifel | Initiate | Buy |
| 2021-07-26 | Credit Suisse | Initiate | Outperform |
| 2021-07-26 | B of A Securities | Initiate | Neutral |